News

Frost & Sullivan’s 2026 Global Company of the Year

12 May 2026

Frost & Sullivan’s 2026 Global Company of the Year

Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.

  • Reset
Avance Clinical Launches Renal and Cardiometabolic Center of Excellence to Optimize Patient Recruitment to Elevate Study Success

30 October 2025

Avance Clinical Launches Renal and Cardiometabolic Center of Excellence to Optimize Patient Recruitment to Elevate Study Success

Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence.

Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience

28 October 2025

Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience

Avance Clinical announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.

Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials

20 October 2025

Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials

Avance Clinical today announced the launch of its dedicated Early Phase Center of Excellence for Biotechs

Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, and Regional Collaboration

25 September 2025

Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, and Regional Collaboration

Avance Clinical, a global CRO headquartered in South Australia, met with Mr Jeff Robinson, South Australian Ambassador to Korea, to advance collaboration opportunities between South Australia and Korea in biotech clinical research.

Avance Clinical Attends Reception Welcoming Australia’s US Ambassador to North Carolina Governor’s Executive Mansion in Raleigh, N.C.

9 September 2025

Avance Clinical Attends Reception Welcoming Australia’s US Ambassador to North Carolina Governor’s Executive Mansion in Raleigh, N.C.

On September 3, 2025, Avance Clinical was honored to attend a special reception at the Executive Mansion in Raleigh, North Carolina, hosted by Governor Josh Stein to welcome His Excellency, The Honorable Kevin Rudd AC, Australia’s Ambassador to the United States.

Avance Clinical Accelerates Time to Pivotal Milestones for More Than 700 Emerging Biotechs

27 August 2025

Avance Clinical Accelerates Time to Pivotal Milestones for More Than 700 Emerging Biotechs

Avance Clinical has now guided 710 emerging biotechs through critical clinical trial inflection points.

Avance Clinical Appoints Mark Harvill as Chief Executive Officer

6 June 2025

Avance Clinical Appoints Mark Harvill as Chief Executive Officer

Avance Clinical, a leading CRO for early-phase and Phase II biotech trials in Australia, the APAC region and the U.S., has appointed Mark Harvill as Chief Executive Officer.

Australia Delivers Certainty for US Biotechs in 2025

28 May 2025

Australia Delivers Certainty for US Biotechs in 2025

As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials.

Avance Clinical Honored with Frost & Sullivan’s 2025 Global Customer Value Leadership Award  for Transformative Biotech CRO Services

15 May 2025

Avance Clinical Honored with Frost & Sullivan’s 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services

This award recognizes Avance Clinical’s strategic innovation, operational agility, and unwavering commitment to client success in early-phase clinical trials.

Avance Clinical to Showcase Asia-Pacific Clinical Trial Expertise at BIO KOREA 2025

15 April 2025

Avance Clinical to Showcase Asia-Pacific Clinical Trial Expertise at BIO KOREA 2025

Avance Clinical will attend BIO Korea 2025 to meet with biotechs and share clinical trial capabilities across the region including Australia, New Zealand, South Korea, Taiwan, North America and beyond.

Frost & Sullivan Interview – Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

3 April 2025

Frost & Sullivan Interview – Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

The biotech Contract Research Organization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs.

Strategic Partnership Between Avance Clinical and Kaohsiung Medical University Chung-Ho Memorial Hospital- Strengthens Asia’s Clinical Trial Network

21 March 2025

Strategic Partnership Between Avance Clinical and Kaohsiung Medical University Chung-Ho Memorial Hospital- Strengthens Asia’s Clinical Trial Network

Avance Clinical has signed a Memorandum of Understanding (MOU) with Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), a top-tier clinical research hospital in Taiwan, recognized for its excellence in conducting high-quality clinical trials and its leadership in medical innovation.

Proven industry
experience & expertise

500+

Studies in the past 5 years

450+

Experienced team members

18k+

Participants past 5 years

30

Years of CRO experience